IOBT Stock Analysis: Buy, Sell, or Hold?
IOBT - IO Biotech, Inc. Common Stock
$0.29
-0.03 (-8.28%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 04, 2026
Get Alerted When IOBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IOBT this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IOBT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IOBT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IOBT is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.37 to $0.67.
Technical Outlook: Technically, IOBT is in a downtrend. Immediate support is located at $0.21, while resistance sits at $0.58. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: IOBT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.18 (+589.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IOBT is in a downtrend. Immediate support is located at $0.21, while resistance sits at $0.58. Short-term momentum is weak, with the stock down 8.3% recently.
Market Sentiment: IOBT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.18 (+589.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.37 -
$0.67
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
Protect Your Profits
Holding IOBT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-8.3%)
- BULLISH: Trading 589.2% below Wall St target ($2.18)
- CAUTION: 5-day price weakness (-21.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.37 -
$0.67
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.21
Resistance Level
$0.58
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.88
Wall Street Target
$2.18
(+589.2%)
Last updated: January 31, 2026 2:29 AM ET
Data refreshes hourly during market hours. Next update: 3:29 AM
Data refreshes hourly during market hours. Next update: 3:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced IOBT Option Strategies
Professional options setups generated by AI based on today's IOBT price and gamma walls.
